Evidence map›Paper›PMID 27479814›Full record

ArticleInvestigative ophthalmology & visual science2016

Residual Foveal Cone Structure in CNGB3-Associated Achromatopsia.

Christopher S Langlo, Emily J Patterson, Brian P Higgins, Phyllis Summerfelt, Moataz M Razeen, Laura R Erker, Maria Parker, Frederick T Collison, Gerald A Fishman, Christine N Kay and 12 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01846052 (Clinical and Genetic Characterization of Individuals With Achromatopsia), which is not on this map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01846052 completednot on this map

Clinical and Genetic Characterization of Individuals With Achromatopsia

TypeobservationalSponsorBeacon TherapeuticsRan2013 to 2017Enrolled56ConditionsAchromatopsia
3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 109 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Gene Therapy for Achromatopsia.International journal of molecular sciences · 2024
    Review
  13. Intervisit Reproducibility of Foveal Cone Density Metrics.Translational vision science & technology · 2024
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 2 countries.

Christopher S LangloCell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin, United States.
Emily J PattersonOphthalmology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States.
Brian P HigginsOphthalmology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States.
Phyllis SummerfeltOphthalmology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States.
Moataz M RazeenOphthalmology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States 3Alexandria Faculty of Medicine, University of Alexandria, Alexandria, Egypt.
Laura R ErkerCasey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States.
Maria ParkerCasey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States.
Frederick T CollisonPangere Center for Inherited Retinal Diseases, The Chicago Lighthouse, Chicago, Illinois, United States.
Gerald A FishmanPangere Center for Inherited Retinal Diseases, The Chicago Lighthouse, Chicago, Illinois, United States.
Christine N KayVitreoretinal Associates, Gainesville, Florida, United States.
Jing ZhangVitreoretinal Associates, Gainesville, Florida, United States.
Richard G WeleberCasey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States.
Paul YangCasey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States.
David J WilsonCasey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States.
Mark E PennesiCasey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States.
Byron L LamBascom Palmer Eye Institute, University of Miami, Miami, Florida, United States.
John ChiangCasey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States.
Jeffrey D ChulayApplied Genetics Technologies Corporation (AGTC), Alachua, Florida, United States.
Alfredo DubraCell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin, United States 2Ophthalmology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States 9Biophysics, Medical College of Wisconsin, Milwaukee, Wisconsin, Un.
William W HauswirthOphthalmology, University of Florida, Gainesville, Florida, United States.
Joseph CarrollCell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin, United States 2Ophthalmology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States 9Biophysics, Medical College of Wisconsin, Milwaukee, Wisconsin, Un.
ACHM-001 Study Group
Oregon Health & Science University · USMedical College of Wisconsin · USRetina Vitreous Associates of Florida · USAlexandria University · EGApplied Genetic Technologies (United States) · USMiami Dermatology and Laser Institute · USUniversity of Florida · US

Funding

Clincal and Translational Science AwardUL1TR000055 · NCATS · MEDICAL COLLEGE OF WISCONSIN · PI SHAKER, REZA NONE · 2012 to 2015
$11.3M
MORPHOLOGY MODULEP30EY001931 · NEI · MEDICAL COLLEGE OF WISCONSIN · PI O'BRIEN, WILLIAM J · 1985 to 2016
$9.8M
Assessing Photoreceptor Structure and Function in Normal and Diseased RetinaeR01EY017607 · NEI · MEDICAL COLLEGE OF WISCONSIN · PI Joseph Carroll · 2008 to 2026
$8.3M
rAAV-CNGB3 Gene Therapy for Achromatopsia: Translational Research StudiesR24EY022023 · NEI · UNIVERSITY OF FLORIDA · PI HAUSWIRTH, WILLIAM W · 2013 to 2017
$7.9M
Medical Scientist Training ProgramT32GM080202 · NIGMS · MEDICAL COLLEGE OF WISCONSIN · PI BARBIERI, JOSEPH T, SALZMAN, NITA H · 2010 to 2024
$5.7M
Platform Technologies for Microscopic Retinal Imaging: Development & TranslationU01EY025477 · NEI · STANFORD UNIVERSITY · PI DUBRA, ALFREDO · 2015 to 2019
$4.4M
Rresearch Training Program in Vision ScienceT32EY014537 · NEI · MEDICAL COLLEGE OF WISCONSIN · PI Elena V Semina · 2002 to 2026
$4.2M
J. NRSA Training CoreTL1TR001437 · NCATS · MEDICAL COLLEGE OF WISCONSIN · PI THOMAS, DANNY GEORGE · 2015 to 2024
$3.7M
Vision Research CoreP30EY021721 · NEI · UNIVERSITY OF FLORIDA · PI HAUSWIRTH, WILLIAM W · 2011 to 2015
$2.8M
VISION RES LAB: HERPETIC KERATIC, CORE PIGMENT GENES, RETINITIS PIGMENTOSAC06RR016511 · NCRR · MEDICAL COLLEGE OF WISCONSIN · PI DUNN, MICHAEL J · 2002 to 2002
$1.4M
Neuroprotective Mechanisms of Inosine Monophosphate Dehydrogenase Inhibitors in Retinitis PigmentosaK08EY026650 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI YANG, PAUL · 2016 to 2020
$1.1M
Serotonin Receptor Modulation of Neurotrophic Factors in the RetinaK08EY021186 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI PENNESI, MARK E · 2011 to 2015
$824k
NCATS NIH HHS UL1 TR000055NCRR NIH HHS C06 RR016511NEI NIH HHS K08 EY021186NEI NIH HHS K08 EY026650NEI NIH HHS P30 EY001931NEI NIH HHS P30 EY021721NEI NIH HHS R01 EY017607NEI NIH HHS R24 EY022023NEI NIH HHS T32 EY014537NEI NIH HHS U01 EY025477NIGMS NIH HHS T32 GM080202
6 · The paper itself

Abstract

purposeCongenital achromatopsia (ACHM) is an autosomal recessive disorder in which cone function is absent or severely reduced. Gene therapy in animal models of ACHM have shown restoration of cone function, though translation of these results to humans relies, in part, on the presence of viable cone photoreceptors at the time of treatment. Here, we characterized residual cone structure in subjects with CNGB3-associated ACHM.

methodsHigh-resolution imaging (optical coherence tomography [OCT] and adaptive optics scanning light ophthalmoscopy [AOSLO]) was performed in 51 subjects with CNGB3-associated ACHM. Peak cone density and inter-cone spacing at the fovea was measured using split-detection AOSLO. Foveal outer nuclear layer thickness was measured in OCT images, and the integrity of the photoreceptor layer was assessed using a previously published OCT grading scheme.

resultsAnalyzable images of the foveal cones were obtained in 26 of 51 subjects, with nystagmus representing the major obstacle to obtaining high-quality images. Peak foveal cone density ranged from 7,273 to 53,554 cones/mm2, significantly lower than normal (range, 84,733-234,391 cones/mm2), with the remnant cones being either contiguously or sparsely arranged. Peak cone density was correlated with OCT integrity grade; however, there was overlap of the density ranges between OCT grades.

conclusionsThe degree of residual foveal cone structure varies greatly among subjects with CNGB3-associated ACHM. Such measurements may be useful in estimating the therapeutic potential of a given retina, providing affected individuals and physicians with valuable information to more accurately assess the risk-benefit ratio as they consider enrolling in experimental gene therapy trials. (www.clinicaltrials.gov, NCT01846052.).

Indexed as

MutationVisual AcuityAdolescentAdultChildColor Vision DefectsCyclic Nucleotide-Gated Cation ChannelsDNADNA Mutational AnalysisElectroretinographyFovea CentralisHumansMiddle AgedOphthalmoscopyRetinal Cone Photoreceptor CellsTomography, Optical CoherenceCNGB3 protein, humanCyclic Nucleotide-Gated Cation ChannelsDNA

Identifiers

PMID27479814
PMCPMC4978151
OpenAlexW2482896879

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.